aktuelle Drittmittel
![](/imperia/md/images/pathophysiologie/fittosize__805_0_7e4d68b7dc00daef3cfe9f607f307c2a_cost_schmaler.png)
European Cooperation in Science and Technology (COST) - CA22169
Thema: EUropean network to tackle METAbolic alterations in HEART failure (EU-METAHEART)
Grant Awarding Coordinator: Univ.-Prof. Dr. rer. nat. Petra Kleinbongard
Working Group Co-Leader WG2 and Management Committee / Germany: em. Univ.-Prof. Dr. med. Dr. h.c. Gerd Heusch
Förderzeitraum: 2023-2027
![](/imperia/md/images/pathophysiologie/fittosize__805_0_da710923347a321829033b90fed859d3_tcrep_ami_hr1.jpg)
Graduiertenkolleg RTG 2989
Thema: Targeting Cellular Interfaces in Reperfused Acute Myocardial Infarction (TCIrep AMI)
Teilprojekt P5: Signal transfer of RIC in patients undergoing coronary artery bypass grafting
Projektleitung: Univ.-Prof. Dr. rer. nat. Petra Kleinbongard und Prof. Dr. med. Markus Kamler
Förderzeitraum: ab April 2024
![](/imperia/md/images/pathophysiologie/fittosize__805_0_95c3694adc02944cb38c350934171875_dfg_neu_neu.png)
Sonderforschungsbereich SFB 1116 der Deutschen Forschungsgemeinschaft / Teilprojekt B8
Thema: Master switches bei kardialer Ischämie / Remote Perconditioning
Teilprojektleitung: Univ.-Prof. Dr. med. Dr. h.c. Gerd Heusch und Univ.-Prof. Dr. rer. nat. Petra Kleinbongard
Förderzeitraum: 2015 - 2022
![](/imperia/md/images/pathophysiologie/fittosize__805_0_7e4d68b7dc00daef3cfe9f607f307c2a_cost_schmaler.png)
European Cooperation in Science and Technology (COST) - COST ACTION CA16225 -
Thema: Realising the therapeutic potential of novel cardioprotective therapies
Teilprojektleitung: Univ.-Prof. Dr. med. Dr. h.c. Gerd Heusch
Förderzeitraum: 2017-2022